Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec;29(6):618-627.
doi: 10.1080/09540261.2017.1398139. Epub 2017 Dec 5.

Positron emission tomography in Parkinson's disease: insights into impulsivity

Affiliations
Review

Positron emission tomography in Parkinson's disease: insights into impulsivity

Adam J Stark et al. Int Rev Psychiatry. 2017 Dec.

Abstract

This study reviews previous studies that employ positron emission tomography (PET) imaging assessments in Parkinson's disease (PD) patients with and without Impulsive Compulsive Behaviours (ICB). This begins with a summary of the potential benefits and limitations of commonly utilized ligands, specifically D2/3 receptor and dopamine transporter ligands. Since previous findings emphasize the role of the ventral striatum in the manifestation of ICBs, this study attempts to relate these imaging findings to changes in behaviour, especially emphasizing work performed in substance abuse and addiction. Next, it reviews how increasing disease duration in PD can influence dopamine receptor expression, with an emphasis on differential striatal and extra-striatal changes that occur along the course of PD. Finally, it focuses on how extra-striatal changes, particularly in the orbitofrontal cortex, amygdala, and anterior cingulate, may influence the proficiency of behavioural regulation in PD. The discussion emphasizes the interaction of disease and medication effects on network-wide changes that occur in PD, and how these changes may result in behavioural dysregulation.

Keywords: PET imaging; Parkinson’s disease; dopamine receptors; impulse control; ventral striatum.

PubMed Disclaimer

Conflict of interest statement

Disclosure statement

D.C. has received personal fees from AbbVie, Acadia, Huntington Study Group, Lundbeck, Neurocrine, Teva Neuroscience, outside of submitted work. A.S. has no conflicts of interest.

Similar articles

Cited by

References

    1. Antonini A, Schwarz J, Oertel WH, Beer HF, Madeja UD, & Leenders KL (1994). [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson’s disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors. Neurology, 44, 1325–1329. doi:10.1212/WNL.44.7.1325 - DOI - PubMed
    1. Antonini A, Schwarz J, Oertel WH, Pogarell O, & Leenders KL (1997). Long-term changes of striatal dopamine D2 receptors in patients with Parkinson’s disease: A study with positron emission tomography and [11C]raclopride. Mov Disord, 12, 33–38. doi:10.1002/mds.870120107 - DOI - PubMed
    1. Baarendse PJ, & Vanderschuren LJ (2012). Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats. Psychopharmacology (Berlin), 219, 313–326. doi:10.1007/s00213-011-2576-x - DOI - PMC - PubMed
    1. Bodi N, Keri S, Nagy H, Moustafa A, Myers CE, Daw N, … Gluck MA (2009). Reward-learning and the novelty-seeking personality: A between- and within- subjects study of the effects of dopamine agonists on young Parkinson’s patients. Brain, 132, 2385–2395. doi:10.1093/brain/awp094 - DOI - PMC - PubMed
    1. Boileau I, Guttman M, Rusjan P, Adams JR, Houle S, Tong J,Kish SJ (2009). Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson’s disease. Brain, 132, 1366–1375. doi:10.1093/brain/awn337 - DOI - PubMed

Publication types

Substances

LinkOut - more resources